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Abstract
Objective: The impact of fast changes in obesity indices on other measures of metabolic health is poorly defined in the
general population. Using the Polish accession to the European Union as a model of political and social transformation we
examined how an expected rapid increase in body mass index (BMI) and waist circumference relates to changes in lipid
profile, both at the population and personal level.
Methods: Through primary care centres in 444 Polish cities, two cross-sectional nationwide population-based surveys
(LIPIDOGRAM 2004 and LIPIDOGRAM 2006) examined 15,404 and 15,453 adult individuals in 2004 and 2006, respectively. A
separate prospective sample of 1,840 individuals recruited in 2004 had a follow-up in 2006 (LIPIDOGRAM PLUS).
Results: Two years after Polish accession to European Union, mean population BMI and waist circumference increased by
0.6% and 0.9%, respectively. This tracked with a 7.6% drop in HDL-cholesterol and a 2.1% increase in triglycerides (all
p,0.001) nationwide. The direction and magnitude of the population changes were replicated at the personal level in
LIPIDOGRAM PLUS (0.7%, 0.3%, 8.6% and 1.8%, respectively). However, increases in BMI and waist circumference were both
only weakly associated with HDL-cholesterol and triglycerides changes prospectively. The relation of BMI to the magnitude
of change in both lipid fractions was comparable to that of waist circumference.
Conclusions: Moderate changes in obesity measures tracked with a significant deterioration in measures of pro-atherogenic
dyslipidaemia at both personal and population level. These associations were predominantly driven by factors not
measureable directly through either BMI or waist circumference.
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Introduction
Clinical measures of obesity such as body mass index (BMI),
waist circumference and waist/height ratio are strong risk
factors of cardiovascular and metabolic diseases [1–4]. The
central role of obesity in cardiovascular disorders is undisputed
[5]. It is also widely acknowledged that the effect of obesity on
cardiovascular disease is at least partly mediated by its
traditional risk factors including lipids [6,7]. However, the
exact mechanisms underlying relationships between BMI/waist
indices and circulating levels of lipids remain elusive. In fact,
there is a surprising paucity of epidemiological studies that have
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investigated the impact of changes in abdominal and general
obesity measures on lipids. In particular, it is not clear to what
extent increasing obesity at the population level is associated
with a deteriorating lipid profile. It is also unknown whether
increasing visceral obesity (i.e. best approximated simply by
waist circumference) at the population levels may have a
stronger relationship with deteriorating lipid profile than
changes in general obesity (assessed by BMI).
To examine the extent of association between changes in
measures of obesity and lipids we took advantage of data collected
in an exceptional ‘‘experiment of history’’ – the accession of
Poland to the European Union in 2004. We hypothesised that the
economic and social consequences of this major political
development in Europe would lead to rapid changes in measures
of obesity and that these changes may have a significant impact on
circulating levels of lipids in the Polish population. We chose to
quantify and relate the short-term (2-year) changes in both
measures of obesity to lipids initially at the population (cross-
sectional analysis) and then seek independent replication of the
findings at the personal level (prospective level).
Materials and Methods
Study Populations
LIPIDOGRAM was a nationwide survey of cardiovascular risk
factors carried out through primary care outpatient centres in
Poland right after Polish accession to the EU (2004) and two years
later (2006). In 2004, a total of 700 doctors in 16 major
administrative regions in Poland were invited to recruit up to 30
consecutive adults attending their primary care practices into this
study. Between October and December 2004 a total of 675
primary care specialists actively enrolled 17,522 individuals in 444
cities. Of these 15,404 were recruited into the cross-sectional arm
(no follow-up; LIPIDOGRAM2004) and 2,118 into a separate
prospective observation with a planned follow-up in 2006
(LIPIDOGRAM PLUS).
Between October and December 2006, 556 primary care
practitioners (82.4% of those recruiting in 2004) from 402 Polish
cities recruited a total of 15,465 individuals into another cross-
sectional analysis (LIPIODGRAM2006). In addition, individuals
recruited into LIPIDOGRAM PLUS in 2004 had their follow-up
in 2006. None of the participants recruited into the cross-sectional
analysis in 2004 were included in the population survey in 2006.
There was also no overlap in individuals recruited into the cross-
sectional and the prospective studies.
The number of recruitment centres across 16 major adminis-
trative regions of Poland as well as the number of individuals
recruited in each region and included in analysis was a direct
function of demographic size of each region (Table S1). These
proportions were retained in 2004 and 2006 in the cross-sectional
surveys as well as in the prospective analysis (Tables S1–2 and
Figures S1–3). All recruiting medical practitioners underwent a
formal training in the study protocol, procedures and collection of
the standardised questionnaires and blood samples.
Eligible for recruitment were individuals aged at least 30 years
who attended an appointment in the primary care during the
recruitment period. The exclusion criteria were dementia/mental
disease resulting in inability to give an informed consent, and
incomplete clinical or biochemical information. Each individual
was phenotyped according to the protocol introduced in
LIPIDOGRAM2004 and described in detail before [2]. In brief,
phenotyping included collection of basic demographic and clinical
data by standardised coded questionnaires, anthropometric
measurements (weight, height, waist circumference) and fasting
blood sample for further biochemical analyses. Weight and height
measurements were carried out without heavy clothing and shoes.
Waist circumference was measured over the unclothed abdomen
at a level of the midpoint between the lower margin of the ribs and
the anterior superior iliac crest spine [2]. Smoking was defined as
current smoking of at least 1cigarette/day. All patients were of
white Polish ethnicity.
All participants provided written informed consent. The study
was approved by the Bioethical Committee of the Polish Chamber
of Physicians (No 51/2004/U) and conforms to the principles
outlined in the Declaration of Helsinki.
Biochemical Analyses
Blood samples were taken under fasting (for at least 12 hours)
conditions. Blood samples were centrifuged locally and separated
serum samples were transferred by one contracted courier
company to the central facility where all biochemical analyses
were conducted within 12 hours after blood collection. All
biochemical measurements (serum) were conducted in the same
International Organization for Standardization (ISO) certified
laboratory and under the same experimental conditions on an
automatic bio-analyzer (ARCHITECT-c8000, ABBOTT Labo-
ratories, USA). Serum concentrations of total cholesterol were
measured using a photometric method with cholesterol oxidase
(DiaSys – Diagnostic Systems, Germany). HDL-cholesterol (HDL-
C) and triglycerides were analyzed by immuno-separation-based
homogenous assay and colorimetric enzymatic test with glycerol-3-
phosphateoxidase, respectively (both DiaSys – Diagnostic Systems,
Germany). The intra-assay and inter-assay coefficients of variation
for total cholesterol, HDL-C and triglycerides were low (0.61, 1.22
and 0.41, 0.83 and 1.23, 1.60, respectively). LDL-cholesterol
(LDL-C) was calculated using the Friedewald formula in those
whose triglycerides were measured ,4.5 mmol/L.
Internal tests of accuracy and precision were conducted by using
CDC-certified lyophilised human serum control samples (includ-
ing those with high, normal and low values for each directly
measured lipid fraction) together with participants’ samples in
each run. Total error (TE – a measure that combines analytical
imprecision and systematic bias) for each of these lipid fractions
was calculated using the formula: TE = Bias(%)+2CV and never
exceeded the total allowable error calculated at 9% for TC, 14%
for TG and 16% for HDL-C. The national external audit of
quality control (National Research Centre for Quality in
Laboratory Diagnostics, Lodz, Poland) and the international
accreditation of the external control (Labquality, Helsinki, Finland
and INSTAND e.V., Du¨sseldorf, Germany) were conducted both
in 2004 and 2006 and confirmed good quality standards for lipids
measurements.
Statistical Analysis
Changes in quantitative metabolic variables were analysed using
linear models fitted by standard regression to the cross-sectional
data and by Generalized Estimating Equations to the prospective
data. Triglycerides were log-transformed prior to regression
analysis and back-transformed into the original measurement
scale (data are presented as geometric means and their standard
errors). All models included a term for the survey year (coded as
2004 = 0, 2006 = 1). Fully adjusted regression models included
terms for age, age2, sex, height, region of recruitment, current
smoking and education (coded as primary, secondary or higher).
Sex differences in changes in measures obesity and lipids were
examined by comparison of corresponding regression coefficients
using Wald (z-statistic) tests.
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In the prospective LIPIDOGRAM PLUS study, adjusted and
unadjusted tests for linear trend were used to examine association
between changes in lipids (as a continuous measure) across
categorised change in BMI/waist circumference.
Results
The general and sex-stratified clinical characteristics of the
study groups are summarised in Table 1 and Tables S3–4. A
total of 14,849 and 15,453 individuals recruited into the cross-
sectional survey in 2004 and 2006 were included in this analysis
after excluding those with missing or inconsistent information. A
total of 1,840 individuals with full demographic and biochemical
data recruited in 2004 into the prospective LIPIDOGRAM PLUS
were surveyed again in 2006 (follow-up rate –86.9%).
In the cross-sectional study adjusted BMI and waist circumfer-
ence increased between 2004 and 2006 by approximately 0.6%
[0.18 (0.05) kg/m2, P,0.001] and 0.9% [0.86 (0.14) cm,
P,0.001], respectively (Table 2). These changes in the popula-
tion were mirrored at the individual level; BMI increased by 0.7%
[0.2 (0.05) kg/m2, P,0.001] and waist circumference by 0.3%
[0.28 (0.16) cm, P = 0.09] in LIPIDOGRAM PLUS (Table 2).
The direction of change in both indices of obesity between 2004
and 2006 was similar in both sexes, although the increasing trend
was generally more prominent in men (Table S5).
Of four lipid fractions the most significant change over the two-
year observation period was observed in circulating concentrations
of HDL-C. After adjustment, HDL-C dropped by 7.6% [0.125
(0.004) mmol/L, P,0.001] nationwide. The increase in circulat-
ing concentrations of triglycerides was calculated at 2.1%
(P,0.001) (Table 2). Serum levels of LDL-C levels remained
essentially constant whilst total cholesterol dropped by 1.7%
(P,0.001) in the surveyed population (Table 2). The direction
and magnitude of changes in lipids in the prospective LIPIDO-
GRAM PLUS were very similar; a 8.6% drop in HDL-C
(P,0.001) was accompanied by a 1.8% increase in triglycerides
(P,0.001), a 2.8% decrease in total cholesterol (P,0.001) and no
changes in LDL-C (Table 2). These trends were also apparent in
sex-specific analysis with very little difference in the magnitude of
the changes in lipids between men and women over the two-year
observation period (Table S5).
Table 1. General clinical characteristics of LIPIDOGRAM2004, LIPIDOGRAM2006 and LIPIDOGRAM PLUS Studies.
Characteristic Cross-sectional Prospective
2004 2006 P-value 2004 2006 P-value
N 14849 15453 – 1840 1840 –
Men (%) 6004 (40.4) 5806 (37.6) ,0.001 712 (38.7) 712 (38.7) –
Age (years) 55.4 (10.7) 55.5 (11.1) 0.46 53.3 (9.7) 55.3 (9.7) –
Height (cm) 166.4 (8.6) 166.1 (8.4) ,0.001 166.7 (8.5) 166.7 (8.5) –
Weight (kg) 78.3 (15.1) 78.5 (14.9) 0.14 78.0 (14.9) 78.9 (15.1) ,0.001
BMI (kg/m2) 28.2 (4.8) 28.4 (4.6) ,0.001 28.0 (4.6) 28.3 (4.6) ,0.001
Waist (cm) 92.4 (13.1) 93.1 (13.0) ,0.001 91.3 (12.5) 92.1 (12.5) ,0.001
HDL-C (mmol/L) 1.65 (0.39) 1.53 (0.38) ,0.001 1.68 (0.41) 1.54 (0.38) ,0.001
TG (mmol/L) 1.49 (0.69) 1.53 (0.64) ,0.001 1.47 (0.69) 1.52 (0.65) ,0.001
TC (mmol/L) 5.76 (1.12) 5.66 (1.13) ,0.001 5.82 (1.15) 5.67 (1.13) ,0.001
LDL-C (mmol/L) 3.36 (0.95) 3.37 (0.99) 0.47 3.40 (0.98) 3.38 (0.99) 0.42
Smokers (%) 3126 (21.1) 2879 (18.6) ,0.001 361 (19.6) 317 (17.2) ,0.001
Treatment (%) 4555 (30.7) 4898 (31.7) 0.06 512 (27.8) 706 (38.4) ,0.001
Data are means and standard deviations, geometric means and standard deviations (triglycerides) or counts and percentages; BMI – body mass index; HDL-C – high-
density lipoprotein cholesterol; TG – triglycerides; TC – total cholesterol; LDL-C – low-density lipoprotein cholesterol; treatment – lipid-lowering medication.
doi:10.1371/journal.pone.0086837.t001
Table 2. Changes in obesity measures and lipids between
2004 and 2006 in the cross-sectional and prospective
LIPIDOGRAM Studies.
Measure Model Cross-sectional Prospective
b (SE) P-value b (SE) P-value
BMI (kg/m2) Basic 0.20 (0.05) ,0.001 0.33 (0.04) ,0.001
Full 0.18 (0.05) ,0.001 0.20 (0.05) ,0.001
Waist (cm) Basic 0.72 (0.15) ,0.001 0.89 (0.15) ,0.001
Full 0.86 (0.14) ,0.001 0.28 (0.16) 0.09
HDL-C
(mmol/L)
Basic 20.119 (0.004) ,0.001 20.147
(0.006)
,0.001
Full 20.125 (0.004) ,0.001 20.145
(0.006)
,0.001
TG (mmol/L) Basic 0.027 (0.005) ,0.001 0.034 (0.009) ,0.001
Full 0.031 (0.005) ,0.001 0.026 (0.009) ,0.001
TC (mmol/L) Basic 20.104 (0.013) ,0.001 20.151
(0.025)
,0.001
Full 20.100 (0.013) ,0.001 20.162
(0.025)
,0.001
LDL-C
(mmol/L)
Basic 0.008 (0.011) 0.46 20.016
(0.022)
0.05
Full 0.015 (0.011) 0.19 20.026
(0.022)
0.24
Data are changes between 2004 and 2006 are expressed as b-coefficients with
standard errors (SE); BMI – body mass index; HDL-C – high-density lipoprotein
cholesterol; TG – triglycerides; TC – total cholesterol; LDL-C – low-density
lipoprotein cholesterol; Basic – unadjusted model; Full – model adjusted for
age, age2, sex, region of recruitment, height, education and smoking.
doi:10.1371/journal.pone.0086837.t002
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We then conducted a sensitivity analysis by selecting 21,983
subjects who were not on pharmacological lipid-lowering treat-
ment (n = 10,294, n = 10,555 and n = 1,134 individuals in
LIPIDOGRAM2004, LIPIDOGRAM2006 and LIPIDOGRAM
PLUS, respectively). As expected, after exclusion of patients on
therapy, LDL-C showed a small increase between 2004 and 2006
in both the cross-sectional and prospective analysis (Table S6).
The trends in other lipids in this sensitivity analysis were consistent
with those in the entire cross-sectional and prospective samples.
Using the data from the LIPIDOGRAM PLUS study we next
assessed whether changes in obesity measures were directly related
to the observed change in HDL-C, triglycerides, and total
cholesterol over the two-year observation period. There was no
direct association between changes in either BMI or waist
circumference and total cholesterol levels (Figure S4 and Table
S7). The linear trends in changes of HDL-C and triglycerides
across the quartiles of BMI/waist circumference change distribu-
tion (Figure 1 and Table S7) were modest. Changes in waist did
not show a greater magnitude of association with HDL-C and
triglycerides than BMI. In fact, the statistical significance of the
association with changes in lipids was weaker for waist than BMI
(Figure 1 and Table S7).
Discussion
We investigated changes in two indices of obesity and main lipid
fractions in a large sample of Polish individuals recruited after a
major political and economic transformation in Europe – the
accession of Poland to the EU in 2004. Economic growth is one
the most important environmental drivers of obesity [8,9]. Indeed,
Figure 1. Relation of changes in obesity measures to changes in lipids in the LIPIDOGRAM PLUS Study. Mean changes in HDL-C (blue
squares) and triglycerides (red circles) across quartiles of changes in BMI (top panel) and waist circumference (bottom panel) between 2004 and 2006.
Data are means and standard errors, the bottom quartile represents subjects from the lowest 25% of distribution in BMI or waist circumference
increase between 2004 and 2006. P-values for trend across quartiles; Padj - adjusted (for age, sex, region of recruitment, height, education and
smoking) level of statistical significance from test for trend.
doi:10.1371/journal.pone.0086837.g001
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socioeconomic transformations of the 1990’s exposed the Eastern
European populations to food market globalization that promotes
processed, high in calories food. Changes in eating cultures and
increasing rates of physical inactivity in the absence of appropriate
health campaigns may have made this region particularly
vulnerable to obesity. We hypothesized that the fast economic
transition related to the European integration would provide an
excellent epidemiological model to examine the relations of an
increasing obesity burden with lipids in the Polish population.
We report several important findings. Firstly, our data
demonstrate the expected increase in major anthropometric
measures of obesity, tracking with a marked deterioration in
HDL-C and triglycerides 2 years after the Polish accession to the
EU. Secondly, the relative changes in these lipid fractions were
actually greater than those of BMI or waist circumference, and
only weakly associated with the increase in indices of obesity.
Thirdly, our survey demonstrates that waist circumference and
BMI are largely comparable as weak metabolic proxies of changes
in lipids in both men and women. Finally, we show for the first
time that the changes in obesity measures and lipids observed in
the nationwide population are largely reproducible at the personal
level.
Very few studies reported how changes in BMI and other
measures of obesity translate into changes in levels of lipids in
individual patients and populations. An increase in measures of
obesity over a period of six–ten years has been associated with a
deterioration of all major lipid fractions [10], components of
metabolic syndrome [11] and incident hypercholesterolemia [12]
in different studies. In contrast, a ten-year observation in the
Framingham Heart Study revealed that an overall increase in BMI
in the population was accompanied by an unexpected increase in
HDL-C and a drop in triglycerides [13]. In our study, a short-term
increase in BMI/waist circumference was paralleled by a
significant deterioration in triglycerides and most apparently –
HDL-C. However, neither the increase in BMI nor the increase in
waist circumference could statistically explain the deterioration in
HDL-C. This means that the observed drop in HDL-C is to a
large extent independent of the parallel increase in BMI or waist
circumference. Prevalence of smoking, another well-known
correlate of low HDL-C [14] actually decreased between 2004
and 2006; thus it is unlikely to explain our findings. Diet, alcohol
consumption and physical activity on their own may also impact
on HDL-C and other lipid fractions, independent on their
contribution to weight balance [15–17]. Insulin resistance and
low-grade inflammation that cluster with excessive weight have
also been shown to affect HDL-C and/or triglycerides, indepen-
dent of adiposity [18,19]. Unfortunately, information on either of
these phenotypes was not available in the LIPIDOGRAM project.
A significant drop in HDL-C largely unexplained by measures of
obesity was reported before in longer observations of general
population [20,21]. These studies relied on BMI as the only
measure of obesity. Our data show that these associations are
apparent even short-term and that using waist circumference does
not offer a better explanation for the change in HDL-C than BMI
and that other factors, not captured directly through either of these
anthropometric indices, may be responsible here.
Parallel to the significant changes in HDL-C, LDL-C was
essentially stable in both the cross-sectional and prospective study.
In the absence of a major change in LDL-C levels the (somewhat
paradoxical) decrease in total cholesterol tracking with increasing
measures of obesity is most likely related to decreasing HDL-C
levels. Our data indicate that the observed drop in total cholesterol
is not related to the use of statins. Indeed, after exclusion of
participants on statin-based treatment, there was an apparent
decreasing trend in total cholesterol despite slightly increasing
LDL-C.
To the best our knowledge this is the first investigation that has
examined changes in metabolic health at both individual and
population level simultaneously using identical protocols. The
availability of prospective personal-level observation in addition to
the two cross-sectional surveys provided also an independent
replication. A consistency in the direction and magnitude of
metabolic changes in both surveys also suggests that there is a good
correlation between personal and nationwide trends in metabolic
health. This consistency is also reassuring given that changes in
cardio-metabolic risk factors from repeated observational studies
are often criticised for providing overestimates due to unmeasured
confounding. To this end our data point to common environ-
mental roots of pro-atherogenic dyslipidaemia in individual
patients and populations.
It would be fair to acknowledge that our data provide only a
snapshot of the changes driven by the long-term process of
political, economic and social transformation in Poland initiated
by the Polish Solidarity movement in 1980s and transition to
market economy in the early 1990s. We also recognise that
LIPIDOGRAM surveys were recruited amongst individuals older
than 30 years and thus may not be fully representative of the
general population structure. The recruitment through primary
care may also lead to over-representation of individuals with ill
health, although a positive or negative bias towards any particular
disease condition is unlikely given the wide inclusion criteria.
Furthermore, the LIPIDOGRAM protocols did not include
questionnaires on eating habits or physical activity. Finally, our
study is observational, and definite causal inferences cannot be
made.
However, our analysis has several strengths. Firstly, the
recruitment strategy, phenotyping, data collection and processing
of all LIPIDOGRAM data were carried out using essentially
identical protocols. To minimise heterogeneity between 2004 and
2006 surveys no new recruitment sites were included in
LIPIDOGRAM2006 and a majority of recruiting investigators
from LIPIDOGRAM2004 participated again in 2006. Secondly,
all surveys were recruited at the same time of the year, minimising
differences related to seasonal variation i.e. in lipids. Thirdly, all
recruiting doctors were trained prior to recruitment to maximise
the standardisation of data collection. Furthermore, to ensure
appropriate representation of individuals from all parts of the
country the number and regional distribution of recruitment sites
in LIPIDOGRAM studies was carefully matched to the demo-
graphic structure of individual geographic regions of Poland. A
unique advantage of our study is that it used a nationwide rather
than community samples. Regional variation in obesity measures
across one country is a well-recognised source of potential
confounding and the recruitment restricted to one community
may not necessarily reflect the nationwide trends in obesity
changes [7]. Finally, to eliminate inter-laboratory variation in
biochemical measurements all blood analyses were conducted in
one central laboratory that conforms to all national and
international quality control standards. Therefore, we have no
reason to suspect that a systematic bias in methodology may have
influenced the findings of our study.
Conclusions
In summary, using data collected in Poland at the time and
shortly after its accession to EU we demonstrate a deterioration of
metabolic health at both personal and population level. The rapid
increase in clinical measures of obesity tracked with a parallel
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deterioration in measures of pro-atherogenic dyslipidaemia,
namely a drop in HDL-C and an increase in triglycerides.
However, the magnitude of change in lipids was far greater than
that of BMI or waist circumference and either measure of obesity
were only weakly associated with changes in lipids. Thus, the
observed deterioration in lipid profile was predominantly driven
by other factors not measureable through BMI or waist
circumference.
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